ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 355063 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 355063; 2) Community: the network communities that were significantly associated with the response to NSC 355063; 3) Molecule: the relationships between components within communities and NSC 355063; 4) MDR: the compounds that were significantly associated with the NSC 355063.

NSC Compound Enrichment Correlation
NSC 622124 Molybdate(6-), hexatriaconta-.mu.-oxooctadecaoxobis[.mu.9-[phosphato(3-)-.kappa.O:.kappa.O:.kappa.O:.kappa.O':.kappa.O':.kappa.O'':.kappa.O'':.kappa.O''':.kappa.O''']]octadeca-, hexapotassium (9CI) 0.0228801759885691 -0.059247543
NSC 626390 Null 0.0228801759885691 -0.3460642
NSC 631477 p-Chloranilinum[bis(p-chloraniline)dioxalatoruthenate(III)] 0.0228801759885691 0.21239731
NSC 632855 9-Chloro-2-methylellipticinium acetate, hydrate 0.0228801759885691 -0.1567955
NSC 654509 Pirarubicin HCl 0.0228801759885691 -0.17893687
NSC 660032 Null 0.0228801759885691 -0.12255874
NSC 665604 Null 0.0228801759885691 0.19141476
NSC 669020 Null 0.0228801759885691 -0.26985099
NSC 675587 Null 0.0228801759885691 0.00050336581
NSC 677020 Benzoic acid, 2-[1,3,4',5'-tetrahydro-1-oxospiro[2H-inden- 2,3'-[3H]pyrazol]-4'-yl]-4-methyl-, methyl ester 0.0228801759885691 0.42193595
Total:69  Current:29    [First] [Prev] [Next] [Last]